Company news

Optiscan Imaging Limited (ASX:OIL) news

Optiscan Imaging Limited news releases on 6ix. Latest, Aug 31, 2020: Appendix 4E and 2020 Annual Report

View Optiscan Imaging Limited →

Press releases — page 3

Appendix 4E and 2020 Annual Report

August 31, 2020

New North American & Expanded Asia Pacific Distribution

August 28, 2020

OIL June 2020 Quarterly Report and Appendix 4C

July 31, 2020

2 X China Tender Success for FIVE2 (ViewnVivo)

July 27, 2020

Government grant to support Melbourne Dental School Trial

July 19, 2020

Achievement of Final Milestone in Carl Zeiss Agreement

May 4, 2020

OIL March 2020 Quarterly Report and Appendix 4C

April 30, 2020

Corporate Update

March 19, 2020

Appendix 4D and Financial Statements - 31 December 2019

February 28, 2020

Corporate Update - January 2020

January 30, 2020

Appointment of Second China Distributor

December 5, 2019

2019 AGM Presentation

November 27, 2019

Optiscan Market Update

November 24, 2019

OIL initiates FDA feedback for Oral Cancer 510(k) submission

November 3, 2019

Appointment of new China Distributor

October 15, 2019

Leading Aus & US Hospital Collaboration to trial OIL device

September 23, 2019

Appendix 4E and 2019 Annual Report

August 30, 2019

Optiscan System Approved for Prestigious Cancer Centre Trial

August 21, 2019

Investor Presentation - June 2019

June 14, 2019

Optiscan Secures Strong Support in $1.70 M Capital Raising

June 13, 2019

OptiScan March 2019 Presentation

March 13, 2019

Appendix 4D and Financial Statements - 31 Dec 2018

February 28, 2019

Collaboration Agreement with Summit Biomedical Imaging LLC

February 26, 2019

OptiScan technology used in research at major cancer centre

February 25, 2019

Reinstatement to Official Quotation

November 6, 2018

Suspension from Official Quotation

November 1, 2018

Clinical Trial - Assessment of Breast Cancer Margin

October 14, 2018

Appendix 4E and 2018 Annual Report

August 31, 2018

Market Update

June 13, 2018

ZEISS CONVIVO and Appointment of Interim Executive Chairman

May 31, 2018

Appendix 4D and Financial Statements - 31 Dec 2017

February 28, 2018

Update on CEO Recruitment and Interim Management

February 15, 2018

Market Update - Resignation of CEO

January 22, 2018

ViewnVivo installed for evaluation at Stanford University

November 16, 2017

First Sales of ViewnVivo in the Chinese Market

November 12, 2017

Zeiss/Optiscan collaboration unveils Convivo

October 9, 2017

Share Purchase Plan and Placement Completion

October 3, 2017

Carl Zeiss Meditec to unveil in vivo Digital Biopsy Tool

September 20, 2017

An update from the Chairman

September 12, 2017

Preliminary Final Report - Appendix 4E

August 29, 2017

Share Placement and Underwritten Share Purchase Plan

August 23, 2017

ViewnVivo Update

August 16, 2017

Investor Presentation - July 2017

July 3, 2017

Optiscan Appoints Exclusive North American Distributor

June 28, 2017

Amended Appendix 4D

March 8, 2017

Appendix 4D and Financial Statements - 31 Dec 2016

February 28, 2017

Cleansing Prospectus

December 27, 2016

Prospectus - Share and Option Issues approved at AGM

December 21, 2016

Share Placement

December 20, 2016

Pre-clinical research product launch

November 22, 2016

← Newer · Older →